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EspFU, a protein secreted by pathogenic enterohaemorrhagic E. coli (EHEC), activates N-WASp/WASp to in-
duce actin pedestal formation in host cells. Two recent papers in Nature show that EspFU exploits a WASp
activation strategy so extreme that it may effectively sequester WASp, blinding it to both autoinhibition and
cellular regulation.
An ever-growing number of pathogens
have been found to co-opt the eukaryotic
actin assembly machinery to promote
their own intracellular movement or adhe-
sion and, ultimately, their survival and
dissemination (Gouin et al., 2005). Intrigu-
ingly, in each of these cases, the hijacking
mechanism involves the pathogen ex-
pressing a protein that recruits the actin-
nucleating Arp2/3 complex by mimicking
either its cellular activator, WASp, or
upstream regulatory factors controlling
WASp activity. Thus, WASp appears to
be the perpetual victim of identity theft.
Early work on Listeria monocytogenes
first opened our eyes to the concept that
pathogenic bacteria can cunningly divert
the actin cytoskeleton of infected host
cells to promote their own intracellular
propulsion and cell-to-cell spreading
(Tilney and Portnoy, 1989). Later the
mechanism came into focus when it was
discovered that ActA, a surface protein
on Listeria, mimics WASp to directly ac-
tivate Arp2/3 complex-mediated actin
assembly (Welch et al., 1998). The list of
culprits that recruit actin assembly ma-
chinery to drive their intracellular motility
has now grown to include the bacteria
Rickettsia, Shigella, Myobacterium, and
Burkholderia, as well as vaccinia virus
(Gouin et al., 2005). A separate group of
nonintracellular pathogens exploit the
actin cytoskeleton by a distinct mecha-
nism that involves attaching themselves
to the surface of the host cell and inducing
local cortical assembly of actin-rich ped-
estals, structures that appear to promote
bacterial colonization. Two such bacteria,
enteropathogenic E. coli (EPEC) and
enterohaemorrhagic E. coli (EHEC), are
human food-borne pathogens that colo-
nize the gutmucosa, leading to ‘‘attaching
and effacing’’ (A/E) lesions and diarrhea.
The focus of the new studies is on EHEC,
which injects host cells with two bacteri-
ally expressed proteins, translocated in-
timin receptor (Tir) and EspFU (also called
TccP). Tir is a transmembrane protein
that is inserted into the host plasmamem-
brane and facilitates bacterial adhesion by
interacting with the bacterial surface pro-
tein intimin (Figure 1). Clustering of Tir
leads to recruitment of EspFU on the cyto-
plasmic side of the hostmembrane, which
in turn recruits and activates WASp to
stimulate actin pedestal formation (Caron
et al., 2006; Frankel and Phillips, 2008).
The new studies from Cheng et al.
(2008) and Sallee et al. (2008) have eluci-
dated the mechanism by which EspFU
activates WASp. In resting cells, WASp
exists in an autoinhibited state, main-
tained by intramolecular interactions be-
tween its GTPase-binding domain (GBD)
and the ‘‘C’’ segment of its VCA domain
(Kim et al., 2000) (Figure 1). In activated
cells, Cdc42, in coordination with phos-
pholipids and SH3-domain-containing
proteins such as Nck, triggers release of
WASp autoinhibition, liberating the VCA
domain to stimulate Arp2/3-complex-me-
diated actin assembly. Structural studies
from Rosen and colleagues have shown
that Cdc42 and the C region of VCA
have nonoverlapping binding sites on
the GBD and induce distinct GBD confor-
mations that preclude simultaneous bind-
ing of both ligands (Buck et al., 2004).
Those observations provided a clear ex-
planation for how Cdc42 releases WASp
autoinhibition. They also led to the predic-
tion that EspFU might mimic Cdc42 to ac-
tivate WASp. However, in an unexpected
twist, Cheng et al. and Sallee et al. show
that a novel mechanism is employed; in-
stead of mimicking Cdc42, EspFU mimics
part of WASp itself.
The effectiveness of EspFU in hijacking
WASp can be explained by the ability of
purified EspFU polypeptides to activate
WASp orders of magnitude more effec-
tively than Cdc42 in vitro, as demon-
strated in both studies. EspFU is largely
composed of five repeated sequences
(47 amino acids in length), each consist-
ing of a short predicted helix followed by
a proline-rich tract. Collective mapping
efforts from the two groups revealed that
a single EspFU repeat is sufficient to
bind WASp with low nanomolar affinity
and potently activate WASp in vitro. In
fact, a single repeat convincingly outper-
forms Cdc42 in activating WASp, and
constructs containing multiple repeats
are even more active. There is some dis-
crepancy between the two studies re-
garding what repeat sequences define
the functional WASp-binding/activation
domain, but future efforts can resolve this.
How then does an EspFU repeat acti-
vate WASp? Using highly complementary
approaches, these two groups discov-
ered that a single repeat binds with high
affinity to the GBD of WASp. Sallee et al.
found that the repeat competes with the
C region of the WASp VCA domain for
binding to GBD, and that the binding site
is separate from the Cdc42 binding site
on GBD. They noted sequence homology
between the repeat and the C region of
VCA at three key hydrophobic residues
that are critical for GBD binding, and thus
concluded that the EspFU repeat mimics
the C region of VCA. Cheng et al. used
NMR-based techniques to demonstrate
a similar biochemical competition and fur-
ther provide anatomic resolution structure
of the EspFU repeat bound to GBD. Their
structure confirms that the helix of the
repeat binds the GBD at precisely the
same site as the C region helix of WASp.
Developmental Cell 15, September 16, 2008 ª2008 Elsevier Inc. 333
Developmental Cell
Previews
Another point of interest is that the EspFU-
bound GBD conformation is nearly super-
imposable with the C-region-bound GBD
conformation. Since this conformation is
incompatible with Cdc42 binding, it sug-
gests that EspFU not only activates WASp
but also blocks its regulation by Cdc42,
further diverting WASp from host cellular
control. Cheng et al. also show that the
three C-like hydrophobic residues found
in theEspFU repeat are essential for activa-
tion of WASp.
If one repeat is sufficient to potently ac-
tivateWASp, why does EspFU contain five
repeats? Both groups found that EspFU
polypeptides with five repeats can bind
five WASp molecules. Further, Sallee
et al. demonstrate that constructs with
an increasing number of repeats exhibit
an increasing potency of EspFU-induced
actin assembly in transfected cells. These
observations raise the tantalizing possibil-
ity that formation of actin pedestals, which
are large, ordered structures, may require
local, organized clustering ofWASpmole-
cules. There is also the role of the EspFU
proline tracts to consider. Do they cluster
SH3-domain-containing proteins, attract
profilin-actin to help raise actin pedestals,
or perform a different function?
These new studies demonstrate a novel
mechanism of pathogen activation of
WASp using a tandem array of superac-
tive C-like repeats. At least one other
pathogenic bacterium (Shigella) has been
shown to activate WASp by disrupting
autoregulation (Egile et al., 1999), so it
will be interesting to learn whether it too
relies on C region mimicry. We should
also keep a lookout for eukaryotic pro-
teins that may utilize the same mecha-
nism to activate WASp under normal
cellular conditions.
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Figure 1. Model for Differential Activation of N-WASp/WASp by Cellular and Pathogenic
Factors
N-WASp/WASp’s autoinhibitory GBD binds its Arp2/3-activating VCA domain. Cdc42 recruits and acti-
vates WASp at the cell surface by binding the WASp GBD at a site distinct from the VCA binding site, al-
tering the conformation of the GBD to block VCA binding. Liberated VCA triggers Arp2/3 complex-medi-
ated actin assembly to build cortical networks. EHEC injects its host cells with two proteins, Tir and EspFU.
Tir spans the plasmamembrane of the host cell and adheres to intimin, an EHEC surface protein. Tir in turn
recruits EspFU molecules, each of which has five C-like domains that competitively disrupt VCA-GBD au-
toregulatory interactions. This leads to local activation of WASp and Arp2/3 complex-mediated assembly
of actin pedestals.
334 Developmental Cell 15, September 16, 2008 ª2008 Elsevier Inc.
Developmental Cell
Previews
